Follow
Dermot Kelleher
Title
Cited by
Cited by
Year
Maintenance therapy with certolizumab pegol for Crohn's disease
S Schreiber, M Khaliq-Kareemi, IC Lawrance, OØ Thomsen, SB Hanauer, ...
New England Journal of Medicine 357 (3), 239-250, 2007
12612007
Multiple common variants for celiac disease influencing immune gene expression
PCA Dubois, G Trynka, L Franke, KA Hunt, J Romanos, A Curtotti, ...
Nature genetics 42 (4), 295-302, 2010
11892010
Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin
E Kenny-Walsh
New England Journal of Medicine 340 (16), 1228-1233, 1999
11551999
A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21
DA Van Heel, L Franke, KA Hunt, R Gwilliam, A Zhernakova, M Inouye, ...
Nature genetics 39 (7), 827-829, 2007
8362007
Newly identified genetic risk variants for celiac disease related to the immune response
KA Hunt, A Zhernakova, G Turner, GAR Heap, L Franke, M Bruinenberg, ...
Nature genetics 40 (4), 395-402, 2008
8302008
Statistical methods for analysis of high-throughput RNA interference screens
A Birmingham, LM Selfors, T Forster, D Wrobel, CJ Kennedy, E Shanks, ...
Nature methods 6 (8), 569-575, 2009
6672009
International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease
DC Fajgenbaum, TS Uldrick, A Bagg, D Frank, D Wu, G Srkalovic, ...
Blood, The Journal of the American Society of Hematology 129 (12), 1646-1657, 2017
4872017
The Neutrophil-Activating Protein (Hp-Nap) of Helicobacter pylori Is a Protective Antigen and a Major Virulence Factor
B Satin, G Del Giudice, V Della Bianca, S Dusi, C Laudanna, F Tonello, ...
The journal of experimental medicine 191 (9), 1467-1476, 2000
4492000
Nanodrug applications in photodynamic therapy
E Paszko, C Ehrhardt, MO Senge, DP Kelleher, JV Reynolds
Photodiagnosis and photodynamic therapy 8 (1), 14-29, 2011
4452011
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy
RJ Farrell, A Murphy, A Long, S Donnelly, A Cherikuri, D O'Toole, ...
Gastroenterology 118 (2), 279-288, 2000
3732000
St John's wort increases expression of P‐glycoprotein: implications for drug interactions
M Hennessy, D Kelleher, JP Spiers, M Barry, P Kavanagh, D Back, ...
British journal of clinical pharmacology 53 (1), 75-82, 2002
3592002
Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source
SM McKiernan, R Hagan, M Curry, GSA McDonald, A Kelly, N Nolan, ...
Hepatology 40 (1), 108-114, 2004
3382004
Activated protein C inhibits lipopolysaccharide‐induced nuclear translocation of nuclear factor κB (NF‐κB) and tumour necrosis factor α (TNF‐α) production in the THP‐1 …
B White, M Schmidt, C Murphy, W Livingstone, D O'toole, M Lawler, ...
British journal of haematology 110 (1), 130-134, 2000
3252000
Nonfunctionalized nanocrystals can exploit a cell's active transport machinery delivering them to specific nuclear and cytoplasmic compartments
I Nabiev, S Mitchell, A Davies, Y Williams, D Kelleher, R Moore, ...
Nano letters 7 (11), 3452-3461, 2007
2932007
Glucocorticoid resistance in inflammatory bowel disease.
RJ Farrell, D Kelleher
The Journal of endocrinology 178 (3), 339-346, 2003
2872003
Idiopathic multicentric Castleman's disease: a systematic literature review
AY Liu, CS Nabel, BS Finkelman, JR Ruth, R Kurzrock, F van Rhee, ...
The Lancet Haematology 3 (4), e163-e175, 2016
2842016
Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low
RJ Farrell, Y Ang, P Kileen, DS O'briain, D Kelleher, PWN Keeling, ...
Gut 47 (4), 514-519, 2000
2712000
Protein kinase C and the cytoskeleton
C Keenan, D Kelleher
Cellular signalling 10 (4), 225-232, 1998
2681998
Dominant influence of an HLA‐B27 restricted CD8+ T cell response in mediating HCV clearance and evolution
C Neumann‐Haefelin, S McKiernan, S Ward, S Viazov, HC Spangenberg, ...
Hepatology 43 (3), 563-572, 2006
2612006
Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data
S Schreiber, JF Colombel, R Bloomfield, S Nikolaus, J Schölmerich, ...
Official journal of the American College of Gastroenterology| ACG 105 (7 …, 2010
2592010
The system can't perform the operation now. Try again later.
Articles 1–20